Modern Retina - ophthalmology news, articles, and events in a timely and accurate manner for members of the ophthalmic ...

Morning Glory Syndrome (MGS) is a rare and complex disease that necessitates a multidisciplinary approach for effective management and enhanced patient outcomes, according to Suping Wu, MD, and ...

Regeneron Pharmaceuticals has announced results from the phase 3 QUASAR trial and its extension study of the phase 3 PULSAR ...

OCU410 is a novel multifunctional modifier gene therapy candidate that targets multiple pathways associated with GA. Ocugen, Inc. completed dosing ahead of schedule in the Phase 2 portion of the Phase ...

Artificial intelligence (AI) is fast developing into an indispensable tool for managing patients with geography atrophy (GA) by facilitating individualized care. However, more refinements to the ...

Modern Retina - ophthalmology news, articles, and events in a timely and accurate manner for members of the ophthalmic community.

Intravitreal injections often feel overwhelming for patients and time-consuming for clinics. From scheduling frequent appointments to ensuring patients receive timely care, the complexity of the ...

The submission deadline for both the 2025 Jenny Pomeroy Award for Excellence in Vision and Public Health and the sixth annual Rising Visionary Award is Monday, March 10, 2025, at noon ET. Prevent ...

The trial will feature the company’s product candidate, AXV101, focused on combating childhood blindness due to retinitis pigmentosa (RP) caused by Bardet-Biedl Syndrome 1 (BBS1). In December 2024, a ...

A recent study of AEYE-DS AI technology used in conjunction with the Topcon NW500 resulted in exceptional clinical diagnostic efficacy. AEYE Health and Topcon Healthcare, Inc., are sharing results of ...